Mark Emkjer has become president and CEO of Accelrys, formerly Pharmacopeia, the company said last week. He was also elected to the company's board of directors. Emkjer had been Accelrys' president since the end of 2002. Previously, he was president and COO of Sunquest Information Systems.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.